KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Prepaid Assets: 2009-2025

Historic Prepaid Assets for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Sep 2025 value amounting to $709.4 million.

  • Vertex Pharmaceuticals' Prepaid Assets rose 57.93% to $709.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $709.4 million, marking a year-over-year increase of 57.93%. This contributed to the annual value of $665.7 million for FY2024, which is 6.73% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Prepaid Assets stood at $709.4 million for Q3 2025, which was up 8.75% from $652.3 million recorded in Q2 2025.
  • Vertex Pharmaceuticals' Prepaid Assets' 5-year high stood at $726.9 million during Q3 2022, with a 5-year trough of $338.9 million in Q1 2021.
  • Over the past 3 years, Vertex Pharmaceuticals' median Prepaid Assets value was $575.4 million (recorded in 2024), while the average stood at $574.1 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first surged by 114.46% in 2021, then dropped by 25.68% in 2023.
  • Quarterly analysis of 5 years shows Vertex Pharmaceuticals' Prepaid Assets stood at $545.8 million in 2021, then increased by 1.41% to $553.5 million in 2022, then grew by 12.68% to $623.7 million in 2023, then rose by 6.73% to $665.7 million in 2024, then soared by 57.93% to $709.4 million in 2025.
  • Its last three reported values are $709.4 million in Q3 2025, $652.3 million for Q2 2025, and $642.8 million during Q1 2025.